[1]
“A New Stability Indicating Method Development And Validation Report For The Assay Of Nivolumab By Rp- Uplc”, Journal of Pharmaceutical Negative Results, pp. 1020–1031, Oct. 2022, doi: 10.47750/pnr.2022.13.S07.143.